Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “ondansetron” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 14
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 14 pipeline programs matching "ondansetron" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

14 results for “ondansetron” Back to intelligence hub

Search results

  1. AD04 (ondansetron)

    ADIAL PHARMACEUTICALS, INC.

    Alcohol Use Disorder

    phase 3 small molecule completed

    1 trial
  2. Ondansetron

    United Therapeutics Europe Ltd

    IBS - Irritable Bowel Syndrome

    phase 3 small molecule completed

    1 trial
  3. Ondansetron

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 2 small molecule completed

    1 trial
  4. Ondansetron

    Takeda

    Nausea

    phase 2 small molecule completed

    1 trial
  5. Ondansetron (ODFS)

    Aquestive Therapeutics

    Nausea and Vomiting, Postoperative

    phase 2 small molecule completed

    1 trial
  6. ondansetron

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial
  7. Ondansetron

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  8. Ondansetron

    HALOZYME THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  9. Ondansetron (ODFS)

    Aquestive Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  10. Ondansetron 8 mg ODFS without water

    Aquestive Therapeutics

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  11. 0 ul of ondansetron

    Hospital Authority, Hong Kong

    Blood Coagulation Disorder

    small molecule active

    1 trial
  12. Ondansetron

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Withdrawal

    small molecule completed

    1 trial
  13. Ondansetron

    United Therapeutics Europe Ltd

    Vomiting of Pregnancy

    small molecule completed

    1 trial
  14. Ondansetron (Zofran)

    United Therapeutics Europe Ltd

    Itching

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.